Venclose Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

Venclose General Information

Description

Developer of endovenous radiofrequency ablation therapy designed to close damaged veins and restore healthy blood flow in patients. The company's therapy offers ease of navigation and positioning, minimizes invasiveness, shows real-time procedure data to inform treatment decisions and offers a simple catheter plug-in, enabling doctors to treat venous reflux.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 2570 North First Street
  • 2nd Floor, Suite 221
  • San Jose, CA 95131
  • United States
+1 (844)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Parent Company
Becton, Dickinson and Company
Vertical(s)
Corporate Office
  • 2570 North First Street
  • 2nd Floor, Suite 221
  • San Jose, CA 95131
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Venclose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 02-Dec-2021 Completed Generating Revenue
4. Debt - PPP 29-Apr-2020 Completed Generating Revenue
3. Later Stage VC (Series C) 27-Nov-2019 Completed Generating Revenue
2. Early Stage VC (Series B) 12-Jul-2018 $14.7M $17.8M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Jun-2015 $3.12M Completed Startup
To view Venclose’s complete valuation and funding history, request access »

Venclose Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 4,030,614 $0.000100 $0.08 $1.04 $1.04 1x $1.04 16.41%
To view Venclose’s complete cap table history, request access »

Venclose Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of endovenous radiofrequency ablation therapy designed to close damaged veins and restore healthy blood flow i
Therapeutic Devices
San Jose, CA
29 As of 2024

Minneapolis, MN
 

Latham, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Venclose Competitors (2)

One of Venclose’s 2 competitors is Medtronic, a Corporation company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN
Angiodynamics Corporation Latham, NY
You’re viewing 2 of 2 competitors. Get the full list »

Venclose Patents

Venclose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260076729-A1 Ablation systems with reduced energy loss Pending 17-Sep-2024
US-12778660-B2 Systems, hubs, and connector assemblies for venous disease treatment Active 29-Oct-2021
US-20250000565-A1 Systems, hubs, and connector assemblies for venous disease treatment Active 29-Oct-2021
WO-2023077054-A1 Systems, hubs, and connector assemblies for venous disease treatment Inactive 29-Oct-2021
AU-2021259843-A1 Methods and systems for venous disease treatment Inactive 24-Apr-2020 A61B18/082
To view Venclose’s complete patent history, request access »

Venclose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Venclose Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ally Bridge Group Growth/Expansion Minority
SCP Ventures Venture Capital Minority
To view Venclose’s complete investors history, request access »

Venclose FAQs

  • When was Venclose founded?

    Venclose was founded in 2014.

  • Where is Venclose headquartered?

    Venclose is headquartered in San Jose, CA.

  • What is the size of Venclose?

    Venclose has 29 total employees.

  • What industry is Venclose in?

    Venclose’s primary industry is Therapeutic Devices.

  • Is Venclose a private or public company?

    Venclose is a Private company.

  • What is Venclose’s current revenue?

    The current revenue for Venclose is .

  • How much funding has Venclose raised over time?

    Venclose has raised $44.9M.

  • Who are Venclose’s investors?

    Ally Bridge Group and SCP Ventures have invested in Venclose.

  • Who are Venclose’s competitors?

    Medtronic and Angiodynamics are competitors of Venclose.

  • When was Venclose acquired?

    Venclose was acquired on 02-Dec-2021.

  • Who acquired Venclose?

    Venclose was acquired by Becton, Dickinson and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process